4.5 Article

Discovery of novel antischistosomal scaffolds from the open access Pandemic Response Box

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Multidisciplinary Sciences

Multistage and transmission-blocking targeted antimalarials discovered from the open-source MMV Pandemic Response Box

Janette Reader et al.

Summary: This study screened the Medicines for Malaria Venture Pandemic Response Box against different life cycle stages of Plasmodium, identifying unique compounds with multistage or stage-specific activity, including potent transmission-blocking drugs. Mechanistic investigations revealed that ML324 inhibits histone demethylation, leading to aberrant gene expression and death in gametocytes, while parasites resistant to SQ109 implicate the V-type H+-ATPase as a druggable target.

NATURE COMMUNICATIONS (2021)

Article Infectious Diseases

Validation of a human-serum-based in vitro growth method for drug screening on juvenile development stages of Schistosoma mansoni

Valentin Buchter et al.

Summary: The study found that the in vitro cultivation of juvenile Schistosoma mansoni can provide worms with similar drug sensitivity, gender distribution, size, and morphology as those collected from rodents, supporting the use of this method in drug screening efforts.

PLOS NEGLECTED TROPICAL DISEASES (2021)

Review Infectious Diseases

Efficacy of praziquantel has been maintained over four decades (from 1977 to 2018): A systematic review and meta-analysis of factors influence its efficacy

Mizuho Fukushige et al.

Summary: The study found that praziquantel treatment for schistosomiasis remains effective even after four decades of usage, with efficacy levels increasing with drug dose. Majority of studies reported high egg reduction rates, even among those with low cure rates. The results support the use of egg reduction rate as an indicator for treatment efficacy and health impact.

PLOS NEGLECTED TROPICAL DISEASES (2021)

Article Clinical Neurology

Efficacy and safety of ozanimod in multiple sclerosis: Dose-blinded extension of a randomized phase II study

Jeffrey A. Cohen et al.

MULTIPLE SCLEROSIS JOURNAL (2019)

Article Parasitology

Multi-center screening of the Pathogen Box collection for schistosomiasis drug discovery

Martina Maccesi et al.

PARASITES & VECTORS (2019)

Article Biochemical Research Methods

Life cycle maintenance and drug-sensitivity assays for early drug discovery in Schistosoma mansoni

Flavio C. Lombardo et al.

NATURE PROTOCOLS (2019)

Review Pharmacology & Pharmacy

Ozanimod for the treatment of relapsing remitting multiple sclerosis

Ludwig Rasche et al.

EXPERT OPINION ON PHARMACOTHERAPY (2018)

Review Infectious Diseases

Mosquitoes and the Lymphatic Filarial Parasites: Research Trends and Budding Roadmaps to Future Disease Eradication

Damilare O. Famakinde

TROPICAL MEDICINE AND INFECTIOUS DISEASE (2018)

Review Infectious Diseases

Elimination of schistosomiasis: the tools required

Robert Bergquist et al.

INFECTIOUS DISEASES OF POVERTY (2017)

Review Infectious Diseases

Controlling schistosomiasis with praziquantel: How much longer without a viable alternative?

Robert Bergquist et al.

INFECTIOUS DISEASES OF POVERTY (2017)

Article Chemistry, Medicinal

Repurposing of a drug scaffold: Identification of novel sila analogues of rimonabant as potent antitubercular agents

Remya Ramesh et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)

Review Chemistry, Medicinal

Target-based molecular modeling strategies for schistosomiasis drug discovery

Leonardo G. Ferreira et al.

FUTURE MEDICINAL CHEMISTRY (2015)

Article Infectious Diseases

Activity Profile of an FDA-Approved Compound Library against Schistosoma mansoni

Gordana Panic et al.

PLOS NEGLECTED TROPICAL DISEASES (2015)

Article Medicine, General & Internal

Human schistosomiasis

Daniel G. Colley et al.

LANCET (2014)

Article Infectious Diseases

Orally Active Antischistosomal Early Leads Identified from the Open Access Malaria Box

Katrin Ingram-Sieber et al.

PLOS NEGLECTED TROPICAL DISEASES (2014)

Review Parasitology

Repurposing drugs for the treatment and control of helminth infections

Gordana Panic et al.

INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2014)

Article Chemistry, Medicinal

Discovery, Synthesis, and Characterization of an Orally Bioavailable, Brain Penetrant Inhibitor of Mixed Lineage Kinase

Val S. Goodfellow et al.

JOURNAL OF MEDICINAL CHEMISTRY (2013)

Article Infectious Diseases

Reduced Susceptibility to Praziquantel among Naturally Occurring Kenyan Isolates of Schistosoma mansoni

Sandra D. Melman et al.

PLOS NEGLECTED TROPICAL DISEASES (2009)

Article Parasitology

Current status of sensitivity to praziquantel in a focus of potential drug resistance in Egypt

S Botros et al.

INTERNATIONAL JOURNAL FOR PARASITOLOGY (2005)

Article Parasitology

Sex- and stage-related sensitivity of Schistosoma mansoni to in vivo and in vitro praziquantel treatment

L Pica-Mattoccia et al.

INTERNATIONAL JOURNAL FOR PARASITOLOGY (2004)

Review Parasitology

Interpreting low praziquantel cure rates of Schistosoma mansoni infections in Senegal

A Danso-Appiah et al.

TRENDS IN PARASITOLOGY (2002)